![]() Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. | |||
Founding Date | Founding Date 2016 | Founding Date 2013 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Redwood City, US HQ Boston, US | Locations Cambridge, US HQ Smithfield, US | Locations Watertown, US HQ Cambridge, US |
Employees | Employees 1438% increase | Employees 17423% increase | Employees 207 |
Valuation ($) | Valuation ($) 116.2 m | Valuation ($) 7.5 m | Valuation ($) 3.1 b |
Financial | |||
Net income | Net income ($116.8m) (FY, 2025) | Net income ($179.7m) (FY, 2022) | Net income ($311.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 145.6m | Total funding raised $ 245m | Total funding raised $ 197m |

Rubius is developing a new class of drugs, Red-Cell Therapeutics™.
View company
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View company